XML 24 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   267,744      
Beginning balance at Dec. 31, 2023 $ 701,304 $ 268 $ 2,539,892 $ 219 $ (1,839,075)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (78,178)       (78,178)
Other comprehensive loss (525)     (525)  
Issuance of common stock in conjunction with equity plans (in shares)   4,536      
Issuance of common stock in conjunction with equity plans 6,891 $ 4 6,887    
Share-based compensation expense 19,525   19,525    
Ending balance (in shares) at Mar. 31, 2024   272,280      
Ending balance at Mar. 31, 2024 $ 649,017 $ 272 2,566,304 (306) (1,917,253)
Beginning balance (in shares) at Dec. 31, 2024 294,418 294,418      
Beginning balance at Dec. 31, 2024 $ 506,594 $ 294 2,654,804 422 (2,148,926)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (426,075)       (426,075)
Other comprehensive loss (41)     (41)  
Issuance of common stock in conjunction with equity plans (in shares)   5,623      
Issuance of common stock in conjunction with equity plans 1,959 $ 6 1,953    
Share-based compensation expense $ 9,201   9,201    
Ending balance (in shares) at Mar. 31, 2025 300,041 300,041      
Ending balance at Mar. 31, 2025 $ 91,638 $ 300 $ 2,665,958 $ 381 $ (2,575,001)